Yantai Lnc Biotechnology Singapore Pte. Ltd.

This early-stage study tested the safety of a new radioactive drug called 177Lu-LNC1004 in adults with advanced solid tumors that have spread or returned. The main goal was to find the highest dose patients could tolerate without severe side effects. Researchers gave small groups…

This early-stage study is testing a new radioactive tracer called 18F-LNC1007 for PET/CT scans. The goal is to see how this tracer moves through the body, how much radiation it delivers, and if it's safe in a small group of 8 healthy volunteers and cancer patients with very small…

This early-stage study tested a new radioactive tracer called 68Ga-LNC1007, which is used for PET scans to detect cancer. It involved 8 total participants, including both healthy adults and people with solid tumors, to see if the injection was safe and to measure how it traveled …